Pharma & Healthcare
Global Advanced Therapy Medicinal Products Market Research Report 2025
- Jul 24, 25
- ID: 404645
- Pages: 81
- Figures: 90
- Views: 4
The global market for Advanced Therapy Medicinal Products was valued at US$ 5769 million in the year 2024 and is projected to reach a revised size of US$ 11140 million by 2031, growing at a CAGR of 10.0% during the forecast period.
Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of disease and injury.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Advanced Therapy Medicinal Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Therapy Medicinal Products.
The Advanced Therapy Medicinal Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Advanced Therapy Medicinal Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Advanced Therapy Medicinal Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Spark Therapeutics
Bluebird Bio
Novartis
UniQure
Celgene Corporation
Gilead Lifesciences
Kolon TissueGene
JCR Pharmaceuticals
MEDIPOST
Vericel Corporation
PHARMICELL
Segment by Type
Cell Therapy
CAR-T Therapy
Gene Therapy
Tissue Engineered Product
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Advanced Therapy Medicinal Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of disease and injury.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Advanced Therapy Medicinal Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Therapy Medicinal Products.
The Advanced Therapy Medicinal Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Advanced Therapy Medicinal Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Advanced Therapy Medicinal Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Spark Therapeutics
Bluebird Bio
Novartis
UniQure
Celgene Corporation
Gilead Lifesciences
Kolon TissueGene
JCR Pharmaceuticals
MEDIPOST
Vericel Corporation
PHARMICELL
Segment by Type
Cell Therapy
CAR-T Therapy
Gene Therapy
Tissue Engineered Product
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Advanced Therapy Medicinal Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Advanced Therapy Medicinal Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Therapy
1.2.3 CAR-T Therapy
1.2.4 Gene Therapy
1.2.5 Tissue Engineered Product
1.3 Market by Application
1.3.1 Global Advanced Therapy Medicinal Products Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Advanced Therapy Medicinal Products Market Perspective (2020-2031)
2.2 Global Advanced Therapy Medicinal Products Growth Trends by Region
2.2.1 Global Advanced Therapy Medicinal Products Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Advanced Therapy Medicinal Products Historic Market Size by Region (2020-2025)
2.2.3 Advanced Therapy Medicinal Products Forecasted Market Size by Region (2026-2031)
2.3 Advanced Therapy Medicinal Products Market Dynamics
2.3.1 Advanced Therapy Medicinal Products Industry Trends
2.3.2 Advanced Therapy Medicinal Products Market Drivers
2.3.3 Advanced Therapy Medicinal Products Market Challenges
2.3.4 Advanced Therapy Medicinal Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Advanced Therapy Medicinal Products Players by Revenue
3.1.1 Global Top Advanced Therapy Medicinal Products Players by Revenue (2020-2025)
3.1.2 Global Advanced Therapy Medicinal Products Revenue Market Share by Players (2020-2025)
3.2 Global Advanced Therapy Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Advanced Therapy Medicinal Products Revenue
3.4 Global Advanced Therapy Medicinal Products Market Concentration Ratio
3.4.1 Global Advanced Therapy Medicinal Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advanced Therapy Medicinal Products Revenue in 2024
3.5 Global Key Players of Advanced Therapy Medicinal Products Head office and Area Served
3.6 Global Key Players of Advanced Therapy Medicinal Products, Product and Application
3.7 Global Key Players of Advanced Therapy Medicinal Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Advanced Therapy Medicinal Products Breakdown Data by Type
4.1 Global Advanced Therapy Medicinal Products Historic Market Size by Type (2020-2025)
4.2 Global Advanced Therapy Medicinal Products Forecasted Market Size by Type (2026-2031)
5 Advanced Therapy Medicinal Products Breakdown Data by Application
5.1 Global Advanced Therapy Medicinal Products Historic Market Size by Application (2020-2025)
5.2 Global Advanced Therapy Medicinal Products Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Advanced Therapy Medicinal Products Market Size (2020-2031)
6.2 North America Advanced Therapy Medicinal Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Advanced Therapy Medicinal Products Market Size by Country (2020-2025)
6.4 North America Advanced Therapy Medicinal Products Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Advanced Therapy Medicinal Products Market Size (2020-2031)
7.2 Europe Advanced Therapy Medicinal Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Advanced Therapy Medicinal Products Market Size by Country (2020-2025)
7.4 Europe Advanced Therapy Medicinal Products Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Advanced Therapy Medicinal Products Market Size (2020-2031)
8.2 Asia-Pacific Advanced Therapy Medicinal Products Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Advanced Therapy Medicinal Products Market Size by Region (2020-2025)
8.4 Asia-Pacific Advanced Therapy Medicinal Products Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Advanced Therapy Medicinal Products Market Size (2020-2031)
9.2 Latin America Advanced Therapy Medicinal Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Advanced Therapy Medicinal Products Market Size by Country (2020-2025)
9.4 Latin America Advanced Therapy Medicinal Products Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Advanced Therapy Medicinal Products Market Size (2020-2031)
10.2 Middle East & Africa Advanced Therapy Medicinal Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2020-2025)
10.4 Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Spark Therapeutics
11.1.1 Spark Therapeutics Company Details
11.1.2 Spark Therapeutics Business Overview
11.1.3 Spark Therapeutics Advanced Therapy Medicinal Products Introduction
11.1.4 Spark Therapeutics Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.1.5 Spark Therapeutics Recent Development
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Details
11.2.2 Bluebird Bio Business Overview
11.2.3 Bluebird Bio Advanced Therapy Medicinal Products Introduction
11.2.4 Bluebird Bio Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.2.5 Bluebird Bio Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Advanced Therapy Medicinal Products Introduction
11.3.4 Novartis Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Advanced Therapy Medicinal Products Introduction
11.4.4 UniQure Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.4.5 UniQure Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Advanced Therapy Medicinal Products Introduction
11.5.4 Celgene Corporation Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.5.5 Celgene Corporation Recent Development
11.6 Gilead Lifesciences
11.6.1 Gilead Lifesciences Company Details
11.6.2 Gilead Lifesciences Business Overview
11.6.3 Gilead Lifesciences Advanced Therapy Medicinal Products Introduction
11.6.4 Gilead Lifesciences Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.6.5 Gilead Lifesciences Recent Development
11.7 Kolon TissueGene
11.7.1 Kolon TissueGene Company Details
11.7.2 Kolon TissueGene Business Overview
11.7.3 Kolon TissueGene Advanced Therapy Medicinal Products Introduction
11.7.4 Kolon TissueGene Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.7.5 Kolon TissueGene Recent Development
11.8 JCR Pharmaceuticals
11.8.1 JCR Pharmaceuticals Company Details
11.8.2 JCR Pharmaceuticals Business Overview
11.8.3 JCR Pharmaceuticals Advanced Therapy Medicinal Products Introduction
11.8.4 JCR Pharmaceuticals Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.8.5 JCR Pharmaceuticals Recent Development
11.9 MEDIPOST
11.9.1 MEDIPOST Company Details
11.9.2 MEDIPOST Business Overview
11.9.3 MEDIPOST Advanced Therapy Medicinal Products Introduction
11.9.4 MEDIPOST Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.9.5 MEDIPOST Recent Development
11.10 Vericel Corporation
11.10.1 Vericel Corporation Company Details
11.10.2 Vericel Corporation Business Overview
11.10.3 Vericel Corporation Advanced Therapy Medicinal Products Introduction
11.10.4 Vericel Corporation Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.10.5 Vericel Corporation Recent Development
11.11 PHARMICELL
11.11.1 PHARMICELL Company Details
11.11.2 PHARMICELL Business Overview
11.11.3 PHARMICELL Advanced Therapy Medicinal Products Introduction
11.11.4 PHARMICELL Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.11.5 PHARMICELL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Advanced Therapy Medicinal Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Therapy
1.2.3 CAR-T Therapy
1.2.4 Gene Therapy
1.2.5 Tissue Engineered Product
1.3 Market by Application
1.3.1 Global Advanced Therapy Medicinal Products Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Advanced Therapy Medicinal Products Market Perspective (2020-2031)
2.2 Global Advanced Therapy Medicinal Products Growth Trends by Region
2.2.1 Global Advanced Therapy Medicinal Products Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Advanced Therapy Medicinal Products Historic Market Size by Region (2020-2025)
2.2.3 Advanced Therapy Medicinal Products Forecasted Market Size by Region (2026-2031)
2.3 Advanced Therapy Medicinal Products Market Dynamics
2.3.1 Advanced Therapy Medicinal Products Industry Trends
2.3.2 Advanced Therapy Medicinal Products Market Drivers
2.3.3 Advanced Therapy Medicinal Products Market Challenges
2.3.4 Advanced Therapy Medicinal Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Advanced Therapy Medicinal Products Players by Revenue
3.1.1 Global Top Advanced Therapy Medicinal Products Players by Revenue (2020-2025)
3.1.2 Global Advanced Therapy Medicinal Products Revenue Market Share by Players (2020-2025)
3.2 Global Advanced Therapy Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Advanced Therapy Medicinal Products Revenue
3.4 Global Advanced Therapy Medicinal Products Market Concentration Ratio
3.4.1 Global Advanced Therapy Medicinal Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advanced Therapy Medicinal Products Revenue in 2024
3.5 Global Key Players of Advanced Therapy Medicinal Products Head office and Area Served
3.6 Global Key Players of Advanced Therapy Medicinal Products, Product and Application
3.7 Global Key Players of Advanced Therapy Medicinal Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Advanced Therapy Medicinal Products Breakdown Data by Type
4.1 Global Advanced Therapy Medicinal Products Historic Market Size by Type (2020-2025)
4.2 Global Advanced Therapy Medicinal Products Forecasted Market Size by Type (2026-2031)
5 Advanced Therapy Medicinal Products Breakdown Data by Application
5.1 Global Advanced Therapy Medicinal Products Historic Market Size by Application (2020-2025)
5.2 Global Advanced Therapy Medicinal Products Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Advanced Therapy Medicinal Products Market Size (2020-2031)
6.2 North America Advanced Therapy Medicinal Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Advanced Therapy Medicinal Products Market Size by Country (2020-2025)
6.4 North America Advanced Therapy Medicinal Products Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Advanced Therapy Medicinal Products Market Size (2020-2031)
7.2 Europe Advanced Therapy Medicinal Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Advanced Therapy Medicinal Products Market Size by Country (2020-2025)
7.4 Europe Advanced Therapy Medicinal Products Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Advanced Therapy Medicinal Products Market Size (2020-2031)
8.2 Asia-Pacific Advanced Therapy Medicinal Products Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Advanced Therapy Medicinal Products Market Size by Region (2020-2025)
8.4 Asia-Pacific Advanced Therapy Medicinal Products Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Advanced Therapy Medicinal Products Market Size (2020-2031)
9.2 Latin America Advanced Therapy Medicinal Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Advanced Therapy Medicinal Products Market Size by Country (2020-2025)
9.4 Latin America Advanced Therapy Medicinal Products Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Advanced Therapy Medicinal Products Market Size (2020-2031)
10.2 Middle East & Africa Advanced Therapy Medicinal Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2020-2025)
10.4 Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Spark Therapeutics
11.1.1 Spark Therapeutics Company Details
11.1.2 Spark Therapeutics Business Overview
11.1.3 Spark Therapeutics Advanced Therapy Medicinal Products Introduction
11.1.4 Spark Therapeutics Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.1.5 Spark Therapeutics Recent Development
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Details
11.2.2 Bluebird Bio Business Overview
11.2.3 Bluebird Bio Advanced Therapy Medicinal Products Introduction
11.2.4 Bluebird Bio Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.2.5 Bluebird Bio Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Advanced Therapy Medicinal Products Introduction
11.3.4 Novartis Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Advanced Therapy Medicinal Products Introduction
11.4.4 UniQure Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.4.5 UniQure Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Advanced Therapy Medicinal Products Introduction
11.5.4 Celgene Corporation Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.5.5 Celgene Corporation Recent Development
11.6 Gilead Lifesciences
11.6.1 Gilead Lifesciences Company Details
11.6.2 Gilead Lifesciences Business Overview
11.6.3 Gilead Lifesciences Advanced Therapy Medicinal Products Introduction
11.6.4 Gilead Lifesciences Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.6.5 Gilead Lifesciences Recent Development
11.7 Kolon TissueGene
11.7.1 Kolon TissueGene Company Details
11.7.2 Kolon TissueGene Business Overview
11.7.3 Kolon TissueGene Advanced Therapy Medicinal Products Introduction
11.7.4 Kolon TissueGene Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.7.5 Kolon TissueGene Recent Development
11.8 JCR Pharmaceuticals
11.8.1 JCR Pharmaceuticals Company Details
11.8.2 JCR Pharmaceuticals Business Overview
11.8.3 JCR Pharmaceuticals Advanced Therapy Medicinal Products Introduction
11.8.4 JCR Pharmaceuticals Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.8.5 JCR Pharmaceuticals Recent Development
11.9 MEDIPOST
11.9.1 MEDIPOST Company Details
11.9.2 MEDIPOST Business Overview
11.9.3 MEDIPOST Advanced Therapy Medicinal Products Introduction
11.9.4 MEDIPOST Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.9.5 MEDIPOST Recent Development
11.10 Vericel Corporation
11.10.1 Vericel Corporation Company Details
11.10.2 Vericel Corporation Business Overview
11.10.3 Vericel Corporation Advanced Therapy Medicinal Products Introduction
11.10.4 Vericel Corporation Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.10.5 Vericel Corporation Recent Development
11.11 PHARMICELL
11.11.1 PHARMICELL Company Details
11.11.2 PHARMICELL Business Overview
11.11.3 PHARMICELL Advanced Therapy Medicinal Products Introduction
11.11.4 PHARMICELL Revenue in Advanced Therapy Medicinal Products Business (2020-2025)
11.11.5 PHARMICELL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Advanced Therapy Medicinal Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Therapy
Table 3. Key Players of CAR-T Therapy
Table 4. Key Players of Gene Therapy
Table 5. Key Players of Tissue Engineered Product
Table 6. Global Advanced Therapy Medicinal Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Advanced Therapy Medicinal Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Advanced Therapy Medicinal Products Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Advanced Therapy Medicinal Products Market Share by Region (2020-2025)
Table 10. Global Advanced Therapy Medicinal Products Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Advanced Therapy Medicinal Products Market Share by Region (2026-2031)
Table 12. Advanced Therapy Medicinal Products Market Trends
Table 13. Advanced Therapy Medicinal Products Market Drivers
Table 14. Advanced Therapy Medicinal Products Market Challenges
Table 15. Advanced Therapy Medicinal Products Market Restraints
Table 16. Global Advanced Therapy Medicinal Products Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Advanced Therapy Medicinal Products Market Share by Players (2020-2025)
Table 18. Global Top Advanced Therapy Medicinal Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Medicinal Products as of 2024)
Table 19. Ranking of Global Top Advanced Therapy Medicinal Products Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Advanced Therapy Medicinal Products Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Advanced Therapy Medicinal Products, Headquarters and Area Served
Table 22. Global Key Players of Advanced Therapy Medicinal Products, Product and Application
Table 23. Global Key Players of Advanced Therapy Medicinal Products, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Advanced Therapy Medicinal Products Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Advanced Therapy Medicinal Products Revenue Market Share by Type (2020-2025)
Table 27. Global Advanced Therapy Medicinal Products Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Advanced Therapy Medicinal Products Revenue Market Share by Type (2026-2031)
Table 29. Global Advanced Therapy Medicinal Products Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Advanced Therapy Medicinal Products Revenue Market Share by Application (2020-2025)
Table 31. Global Advanced Therapy Medicinal Products Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Advanced Therapy Medicinal Products Revenue Market Share by Application (2026-2031)
Table 33. North America Advanced Therapy Medicinal Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Advanced Therapy Medicinal Products Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Advanced Therapy Medicinal Products Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Advanced Therapy Medicinal Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Advanced Therapy Medicinal Products Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Advanced Therapy Medicinal Products Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Advanced Therapy Medicinal Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Advanced Therapy Medicinal Products Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Advanced Therapy Medicinal Products Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Advanced Therapy Medicinal Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Advanced Therapy Medicinal Products Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Advanced Therapy Medicinal Products Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Advanced Therapy Medicinal Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2026-2031) & (US$ Million)
Table 48. Spark Therapeutics Company Details
Table 49. Spark Therapeutics Business Overview
Table 50. Spark Therapeutics Advanced Therapy Medicinal Products Product
Table 51. Spark Therapeutics Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 52. Spark Therapeutics Recent Development
Table 53. Bluebird Bio Company Details
Table 54. Bluebird Bio Business Overview
Table 55. Bluebird Bio Advanced Therapy Medicinal Products Product
Table 56. Bluebird Bio Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 57. Bluebird Bio Recent Development
Table 58. Novartis Company Details
Table 59. Novartis Business Overview
Table 60. Novartis Advanced Therapy Medicinal Products Product
Table 61. Novartis Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. UniQure Company Details
Table 64. UniQure Business Overview
Table 65. UniQure Advanced Therapy Medicinal Products Product
Table 66. UniQure Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 67. UniQure Recent Development
Table 68. Celgene Corporation Company Details
Table 69. Celgene Corporation Business Overview
Table 70. Celgene Corporation Advanced Therapy Medicinal Products Product
Table 71. Celgene Corporation Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 72. Celgene Corporation Recent Development
Table 73. Gilead Lifesciences Company Details
Table 74. Gilead Lifesciences Business Overview
Table 75. Gilead Lifesciences Advanced Therapy Medicinal Products Product
Table 76. Gilead Lifesciences Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 77. Gilead Lifesciences Recent Development
Table 78. Kolon TissueGene Company Details
Table 79. Kolon TissueGene Business Overview
Table 80. Kolon TissueGene Advanced Therapy Medicinal Products Product
Table 81. Kolon TissueGene Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 82. Kolon TissueGene Recent Development
Table 83. JCR Pharmaceuticals Company Details
Table 84. JCR Pharmaceuticals Business Overview
Table 85. JCR Pharmaceuticals Advanced Therapy Medicinal Products Product
Table 86. JCR Pharmaceuticals Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 87. JCR Pharmaceuticals Recent Development
Table 88. MEDIPOST Company Details
Table 89. MEDIPOST Business Overview
Table 90. MEDIPOST Advanced Therapy Medicinal Products Product
Table 91. MEDIPOST Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 92. MEDIPOST Recent Development
Table 93. Vericel Corporation Company Details
Table 94. Vericel Corporation Business Overview
Table 95. Vericel Corporation Advanced Therapy Medicinal Products Product
Table 96. Vericel Corporation Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 97. Vericel Corporation Recent Development
Table 98. PHARMICELL Company Details
Table 99. PHARMICELL Business Overview
Table 100. PHARMICELL Advanced Therapy Medicinal Products Product
Table 101. PHARMICELL Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 102. PHARMICELL Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Advanced Therapy Medicinal Products Picture
Figure 2. Global Advanced Therapy Medicinal Products Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Advanced Therapy Medicinal Products Market Share by Type: 2024 VS 2031
Figure 4. Cell Therapy Features
Figure 5. CAR-T Therapy Features
Figure 6. Gene Therapy Features
Figure 7. Tissue Engineered Product Features
Figure 8. Global Advanced Therapy Medicinal Products Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Advanced Therapy Medicinal Products Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Advanced Therapy Medicinal Products Report Years Considered
Figure 13. Global Advanced Therapy Medicinal Products Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Advanced Therapy Medicinal Products Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Advanced Therapy Medicinal Products Market Share by Region: 2024 VS 2031
Figure 16. Global Advanced Therapy Medicinal Products Market Share by Players in 2024
Figure 17. Global Top Advanced Therapy Medicinal Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Medicinal Products as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Advanced Therapy Medicinal Products Revenue in 2024
Figure 19. North America Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Advanced Therapy Medicinal Products Market Share by Country (2020-2031)
Figure 21. United States Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Advanced Therapy Medicinal Products Market Share by Country (2020-2031)
Figure 25. Germany Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Advanced Therapy Medicinal Products Market Share by Region (2020-2031)
Figure 33. China Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Advanced Therapy Medicinal Products Market Share by Country (2020-2031)
Figure 41. Mexico Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Advanced Therapy Medicinal Products Market Share by Country (2020-2031)
Figure 45. Turkey Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Spark Therapeutics Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 49. Bluebird Bio Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 51. UniQure Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 52. Celgene Corporation Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 53. Gilead Lifesciences Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 54. Kolon TissueGene Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 55. JCR Pharmaceuticals Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 56. MEDIPOST Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 57. Vericel Corporation Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 58. PHARMICELL Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Advanced Therapy Medicinal Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Therapy
Table 3. Key Players of CAR-T Therapy
Table 4. Key Players of Gene Therapy
Table 5. Key Players of Tissue Engineered Product
Table 6. Global Advanced Therapy Medicinal Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Advanced Therapy Medicinal Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Advanced Therapy Medicinal Products Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Advanced Therapy Medicinal Products Market Share by Region (2020-2025)
Table 10. Global Advanced Therapy Medicinal Products Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Advanced Therapy Medicinal Products Market Share by Region (2026-2031)
Table 12. Advanced Therapy Medicinal Products Market Trends
Table 13. Advanced Therapy Medicinal Products Market Drivers
Table 14. Advanced Therapy Medicinal Products Market Challenges
Table 15. Advanced Therapy Medicinal Products Market Restraints
Table 16. Global Advanced Therapy Medicinal Products Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Advanced Therapy Medicinal Products Market Share by Players (2020-2025)
Table 18. Global Top Advanced Therapy Medicinal Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Medicinal Products as of 2024)
Table 19. Ranking of Global Top Advanced Therapy Medicinal Products Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Advanced Therapy Medicinal Products Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Advanced Therapy Medicinal Products, Headquarters and Area Served
Table 22. Global Key Players of Advanced Therapy Medicinal Products, Product and Application
Table 23. Global Key Players of Advanced Therapy Medicinal Products, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Advanced Therapy Medicinal Products Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Advanced Therapy Medicinal Products Revenue Market Share by Type (2020-2025)
Table 27. Global Advanced Therapy Medicinal Products Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Advanced Therapy Medicinal Products Revenue Market Share by Type (2026-2031)
Table 29. Global Advanced Therapy Medicinal Products Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Advanced Therapy Medicinal Products Revenue Market Share by Application (2020-2025)
Table 31. Global Advanced Therapy Medicinal Products Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Advanced Therapy Medicinal Products Revenue Market Share by Application (2026-2031)
Table 33. North America Advanced Therapy Medicinal Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Advanced Therapy Medicinal Products Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Advanced Therapy Medicinal Products Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Advanced Therapy Medicinal Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Advanced Therapy Medicinal Products Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Advanced Therapy Medicinal Products Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Advanced Therapy Medicinal Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Advanced Therapy Medicinal Products Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Advanced Therapy Medicinal Products Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Advanced Therapy Medicinal Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Advanced Therapy Medicinal Products Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Advanced Therapy Medicinal Products Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Advanced Therapy Medicinal Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2026-2031) & (US$ Million)
Table 48. Spark Therapeutics Company Details
Table 49. Spark Therapeutics Business Overview
Table 50. Spark Therapeutics Advanced Therapy Medicinal Products Product
Table 51. Spark Therapeutics Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 52. Spark Therapeutics Recent Development
Table 53. Bluebird Bio Company Details
Table 54. Bluebird Bio Business Overview
Table 55. Bluebird Bio Advanced Therapy Medicinal Products Product
Table 56. Bluebird Bio Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 57. Bluebird Bio Recent Development
Table 58. Novartis Company Details
Table 59. Novartis Business Overview
Table 60. Novartis Advanced Therapy Medicinal Products Product
Table 61. Novartis Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. UniQure Company Details
Table 64. UniQure Business Overview
Table 65. UniQure Advanced Therapy Medicinal Products Product
Table 66. UniQure Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 67. UniQure Recent Development
Table 68. Celgene Corporation Company Details
Table 69. Celgene Corporation Business Overview
Table 70. Celgene Corporation Advanced Therapy Medicinal Products Product
Table 71. Celgene Corporation Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 72. Celgene Corporation Recent Development
Table 73. Gilead Lifesciences Company Details
Table 74. Gilead Lifesciences Business Overview
Table 75. Gilead Lifesciences Advanced Therapy Medicinal Products Product
Table 76. Gilead Lifesciences Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 77. Gilead Lifesciences Recent Development
Table 78. Kolon TissueGene Company Details
Table 79. Kolon TissueGene Business Overview
Table 80. Kolon TissueGene Advanced Therapy Medicinal Products Product
Table 81. Kolon TissueGene Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 82. Kolon TissueGene Recent Development
Table 83. JCR Pharmaceuticals Company Details
Table 84. JCR Pharmaceuticals Business Overview
Table 85. JCR Pharmaceuticals Advanced Therapy Medicinal Products Product
Table 86. JCR Pharmaceuticals Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 87. JCR Pharmaceuticals Recent Development
Table 88. MEDIPOST Company Details
Table 89. MEDIPOST Business Overview
Table 90. MEDIPOST Advanced Therapy Medicinal Products Product
Table 91. MEDIPOST Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 92. MEDIPOST Recent Development
Table 93. Vericel Corporation Company Details
Table 94. Vericel Corporation Business Overview
Table 95. Vericel Corporation Advanced Therapy Medicinal Products Product
Table 96. Vericel Corporation Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 97. Vericel Corporation Recent Development
Table 98. PHARMICELL Company Details
Table 99. PHARMICELL Business Overview
Table 100. PHARMICELL Advanced Therapy Medicinal Products Product
Table 101. PHARMICELL Revenue in Advanced Therapy Medicinal Products Business (2020-2025) & (US$ Million)
Table 102. PHARMICELL Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Advanced Therapy Medicinal Products Picture
Figure 2. Global Advanced Therapy Medicinal Products Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Advanced Therapy Medicinal Products Market Share by Type: 2024 VS 2031
Figure 4. Cell Therapy Features
Figure 5. CAR-T Therapy Features
Figure 6. Gene Therapy Features
Figure 7. Tissue Engineered Product Features
Figure 8. Global Advanced Therapy Medicinal Products Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Advanced Therapy Medicinal Products Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Advanced Therapy Medicinal Products Report Years Considered
Figure 13. Global Advanced Therapy Medicinal Products Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Advanced Therapy Medicinal Products Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Advanced Therapy Medicinal Products Market Share by Region: 2024 VS 2031
Figure 16. Global Advanced Therapy Medicinal Products Market Share by Players in 2024
Figure 17. Global Top Advanced Therapy Medicinal Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Medicinal Products as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Advanced Therapy Medicinal Products Revenue in 2024
Figure 19. North America Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Advanced Therapy Medicinal Products Market Share by Country (2020-2031)
Figure 21. United States Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Advanced Therapy Medicinal Products Market Share by Country (2020-2031)
Figure 25. Germany Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Advanced Therapy Medicinal Products Market Share by Region (2020-2031)
Figure 33. China Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Advanced Therapy Medicinal Products Market Share by Country (2020-2031)
Figure 41. Mexico Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Advanced Therapy Medicinal Products Market Share by Country (2020-2031)
Figure 45. Turkey Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Advanced Therapy Medicinal Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Spark Therapeutics Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 49. Bluebird Bio Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 51. UniQure Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 52. Celgene Corporation Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 53. Gilead Lifesciences Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 54. Kolon TissueGene Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 55. JCR Pharmaceuticals Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 56. MEDIPOST Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 57. Vericel Corporation Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 58. PHARMICELL Revenue Growth Rate in Advanced Therapy Medicinal Products Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232